Carregant...
Termination of Bleeding by a Specific, Anti-catalytic Antibody to Plasmin
BACKGROUND: Excessive, plasmin-mediated fibrinolysis augments bleeding and contributes to death in some patients. Current therapies for fibrinolytic bleeding are limited by modest efficacy, low potency and off-target effects. OBJECTIVES: To determine whether an antibody directed against unique loop...
Guardat en:
| Publicat a: | J Thromb Haemost |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7359864/ https://ncbi.nlm.nih.gov/pubmed/31136076 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.14522 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|